Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers
Sponsor: Duke University
Terminated
Recruitment failed due to lack of subjects meeting the eligibility criteria
Listed as NCT02848586, this NA trial focuses on HIV Seropositivity and Lung Inflammation and remains terminated or withdrawn. Sponsored by Duke University, it has been updated 11 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Aug 2023 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Aug 2023 [monthly]
Terminated NA
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
Status: Suspended → Terminated
▶ Show 6 earlier versions
-
Nov 2019 — Feb 2020 [monthly]
Suspended NA
-
Jan 2019 — Nov 2019 [monthly]
Suspended NA
-
Dec 2018 — Jan 2019 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .